Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 24674374)

1.

Clinical and molecular exploration of the impact of radiation therapy on Marfan syndrome patients.

Blakaj DM, Zhang HG, Blakaj A, Mourad WF, Clarke B, Spierer M, Kalnicki S, Guha C.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):e127-30. doi: 10.1016/j.prro.2012.07.006. Epub 2012 Aug 21. No abstract available.

PMID:
24674374
2.

The importance of genetic testing in the clinical management of patients with Marfan syndrome and related disorders.

Arslan-Kirchner M, von Kodolitsch Y, Schmidtke J.

Dtsch Arztebl Int. 2008 Jul;105(27):483-91. doi: 10.3238/arztebl.2008.0483. Epub 2008 Jul 4.

3.

Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome.

De Backer J, Loeys B, Leroy B, Coucke P, Dietz H, De Paepe A.

Clin Genet. 2007 Sep;72(3):188-98.

PMID:
17718856
4.

Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Li-Wan-Po A, Loeys B, Farndon P, Latham D, Bradley C.

Br J Clin Pharmacol. 2011 Jul;72(1):6-17. doi: 10.1111/j.1365-2125.2011.03929.x. Review.

5.

The cervical spine in Marfan syndrome.

Hobbs WR, Sponseller PD, Weiss AP, Pyeritz RE.

Spine (Phila Pa 1976). 1997 May 1;22(9):983-9.

PMID:
9152448
6.

A clinical severity grading scale for Marfan syndrome.

Gray JR, Davies SJ.

J Med Genet. 1996 Sep;33(9):758-9.

7.

Marfan syndrome. Long-term survival and complications after aortic aneurysm repair.

Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewicz DM.

Circulation. 1995 Feb 1;91(3):728-33.

8.

The prevalence and clinical impact of obesity in adults with Marfan syndrome.

Yetman AT, McCrindle BW.

Can J Cardiol. 2010 Apr;26(4):137-9.

9.

Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.

Faivre L, Masurel-Paulet A, Collod-Béroud G, Callewaert BL, Child AH, Stheneur C, Binquet C, Gautier E, Chevallier B, Huet F, Loeys BL, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Grasso M, Halliday DJ, Béroud C, Bonithon-Kopp C, Claustres M, Robinson PN, Adès L, De Backer J, Coucke P, Francke U, De Paepe A, Boileau C, Jondeau G.

Pediatrics. 2009 Jan;123(1):391-8. doi: 10.1542/peds.2008-0703.

PMID:
19117906
10.

Is the metacarpal index useful in the diagnosis of Marfan syndrome?

Thomas SM, Younger KA, Child A, Wilson AG.

Clin Radiol. 1996 Aug;51(8):570-4.

PMID:
8761395
11.

Marfan syndrome: from gene to therapy.

Bolar N, Van Laer L, Loeys BL.

Curr Opin Pediatr. 2012 Aug;24(4):498-504. doi: 10.1097/MOP.0b013e3283557d4c. Review.

PMID:
22705998
12.

Clinical presentation and echocardiographic findings of Thai patients with Marfan syndrome.

Pithukpakorn M, Chaowalit N.

J Med Assoc Thai. 2010 Jan;93 Suppl 1:S43-7.

PMID:
20364556
13.

Presenting signs and clinical diagnosis in individuals referred to rule out Marfan syndrome.

Hamod A, Moodie D, Clark B, Traboulsi EI.

Ophthalmic Genet. 2003 Mar;24(1):35-9.

PMID:
12660864
14.

What is new in the Marfan syndrome?

Nollen GJ, Mulder BJ.

Int J Cardiol. 2004 Dec;97 Suppl 1:103-8. Review.

PMID:
15590086
15.

Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial.

Radonic T, de Witte P, Baars MJ, Zwinderman AH, Mulder BJ, Groenink M; COMPARE study group.

Trials. 2010 Jan 12;11:3. doi: 10.1186/1745-6215-11-3.

16.

The molecular genetics of Marfan syndrome and related microfibrillopathies.

Robinson PN, Godfrey M.

J Med Genet. 2000 Jan;37(1):9-25. Review.

17.

Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome.

Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE.

Am J Cardiol. 1998 Jul 15;82(2):203-8.

PMID:
9678292
18.

Neurovascular complications of marfan syndrome: a retrospective, hospital-based study.

Wityk RJ, Zanferrari C, Oppenheimer S.

Stroke. 2002 Mar;33(3):680-4.

19.

The value of keratometry and central corneal thickness measurements in the clinical diagnosis of Marfan syndrome.

Heur M, Costin B, Crowe S, Grimm RA, Moran R, Svensson LG, Traboulsi EI.

Am J Ophthalmol. 2008 Jun;145(6):997-1001. doi: 10.1016/j.ajo.2008.01.028. Epub 2008 Apr 18.

PMID:
18378212
20.

Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome.

Hartog AW, Franken R, Zwinderman AH, Groenink M, Mulder BJ.

Expert Opin Pharmacother. 2012 Apr;13(5):647-62. doi: 10.1517/14656566.2012.665446. Epub 2012 Mar 7. Review. Erratum in: Expert Opin Pharmacother. 2012 Jul;13(10):1543.

PMID:
22397493
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk